These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10628802)

  • 1. Analysis of p53 and mdm2 proteins in malignant fibrous histiocytoma in absence of gene alteration: prognostic significance.
    Molina P; Pellín A; Navarro S; Boix J; Carda C; Llombart-Bosch A
    Virchows Arch; 1999 Dec; 435(6):596-605. PubMed ID: 10628802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retroperitoneal liposarcoma with combined well-differentiated and myxoid malignant fibrous histiocytoma-like myxoid areas.
    Hisaoka M; Morimitsu Y; Hashimoto H; Ishida T; Mukai H; Satoh H; Motoi T; Machinami R
    Am J Surg Pathol; 1999 Dec; 23(12):1480-92. PubMed ID: 10584701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2 amplification, P53 mutation, and accumulation of the P53 gene product in malignant fibrous histiocytoma.
    Reid AH; Tsai MM; Venzon DJ; Wright CF; Lack EE; O'Leary TJ
    Diagn Mol Pathol; 1996 Mar; 5(1):65-73. PubMed ID: 8919547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
    Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
    Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
    Leach FS; Tokino T; Meltzer P; Burrell M; Oliner JD; Smith S; Hill DE; Sidransky D; Kinzler KW; Vogelstein B
    Cancer Res; 1993 May; 53(10 Suppl):2231-4. PubMed ID: 8387391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 gene mutation and MDM2 overexpression in a case of primary malignant fibrous histiocytoma of the jejunum.
    Jiao YF; Nakamura S; Sugai T; Habano W; Uesugi N; Oikawa M; Sato T
    APMIS; 2002 Feb; 110(2):165-71. PubMed ID: 12064872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 overexpression is associated with short survival in adults with medulloblastoma.
    Giordana MT; Duó D; Gasverde S; Trevisan E; Boghi A; Morra I; Pradotto L; Mauro A; Chió A
    Neuro Oncol; 2002 Apr; 4(2):115-22. PubMed ID: 11916503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrapleural solitary fibrous tumor: clinicopathologic study of 17 cases and molecular analysis of the p53 pathway.
    Morimitsu Y; Nakajima M; Hisaoka M; Hashimoto H
    APMIS; 2000 Sep; 108(9):617-25. PubMed ID: 11110050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours.
    Yamamoto H; Oda Y; Saito T; Sakamoto A; Miyajima K; Tamiya S; Tsuneyoshi M
    Histopathology; 2003 May; 42(5):431-9. PubMed ID: 12713619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
    Flørenes VA; Maelandsmo GM; Forus A; Andreassen A; Myklebost O; Fodstad O
    J Natl Cancer Inst; 1994 Sep; 86(17):1297-302. PubMed ID: 8064888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas.
    Della Torre G; Pasquini G; Pilotti S; Alasio L; Civelli E; Cozzi G; Milella M; Salvetti M; Pierotti MA; Severini A
    Diagn Mol Pathol; 2000 Mar; 9(1):41-6. PubMed ID: 10718212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical status of p53, mdm2 and Ki-67 in malignant fibrous histiocytoma.
    Szadowska A; Olborski B; Harezga-Bal B; Debiec-Rychter M
    Pol J Pathol; 1998; 49(1):15-21. PubMed ID: 9640970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
    Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
    Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods.
    Lu ML; Wikman F; Orntoft TF; Charytonowicz E; Rabbani F; Zhang Z; Dalbagni G; Pohar KS; Yu G; Cordon-Cardo C
    Clin Cancer Res; 2002 Jan; 8(1):171-9. PubMed ID: 11801555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered p53 expression in benign and malignant skin lesions from renal transplant recipients and immunocompetent patients with skin cancer: correlation with human papillomaviruses?
    O'Connor DP; Kay EW; Leader M; Murphy GM; Atkins GJ; Mabruk MJ
    Diagn Mol Pathol; 2001 Sep; 10(3):190-9. PubMed ID: 11552722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and mutation of the tumor suppressor gene p53 in AIDS-associated Kaposi's sarcoma.
    Li JJ; Huang YQ; Cockerell CJ; Zhang WG; Nicolaides A; Friedman-Kien AE
    Am J Dermatopathol; 1997 Aug; 19(4):373-8. PubMed ID: 9261472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors.
    Günther T; Schneider-Stock R; Rys J; Niezabitowski A; Roessner A
    J Cancer Res Clin Oncol; 1997; 123(7):388-94. PubMed ID: 9260591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.
    Cordon-Cardo C; Latres E; Drobnjak M; Oliva MR; Pollack D; Woodruff JM; Marechal V; Chen J; Brennan MF; Levine AJ
    Cancer Res; 1994 Feb; 54(3):794-9. PubMed ID: 8306343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.